Abstract

Get full access to this article
View all access options for this article.
References
1.
Kalac
M
Quintas-Cardama
A
Vrhovac
R
A critical appraisal of conventional and investigational drug therapy in patients with hypereosinophilic syndrome and clonal eosinophilia. Cancer 2007;110(5):955 –64 .
2.
Helbig
G
Stella-Holowiecka
B
Majewski
M
A single weekly dose of imatinib is sufficient to induce and maintain remission of chronic eosinophilic leukaemia in FIP1L1-PDGFRA-expressing patients. Br J Haematol 2008;141(2):200 –4 .
3.
Rothenberg
ME
Klion
AD
Roufosse
FE
Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med 2008;358(12):1215 –28 .
